SEARCH

SEARCH BY CITATION

References

  • [1]
    Zignego, A.L., Brechot, C. (1999) Extrahepatic manifestations of HCV infection: facts and controversies. J. Hepatol. 31, 369376.
  • [2]
    Bassett, S.E., Thomas, D.L., Brasky, K.M., Lanford, R.E. (1999) Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J. Virol. 73, 11181126.
  • [3]
    Hayashi, J., Aoki, H., Arakawa, Y., Hino, O. (1999) Hepatitis C virus and hepatocarcinogenesis. Intervirology 42, 205210.
  • [4]
    Hagedorn, C.H., Rice, C.M. The hepatitis C viruses Curr. Opin. Microb. Immunol. 242 2000.
  • [5]
    McLauchlan, J. (2000) Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J. Viral Hepatitis 7, 214.
  • [6]
    Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W., Houghton, M. (1989) Isolation of a cDNA clone derived from ablood-borne non-A, non-B viral hepatitis genome. Science 244, 359362.
  • [7]
    Santolini, E., Migliaccio, G., Monica, N.L. (1994) Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68, 36313641.
  • [8]
    Ray, R.B., Lagging, L.M., Meyer, K., Steele, R., Ray, R. (1995) Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37, 209220.
  • [9]
    Lo, S.Y., Selby, M., Tong, M., Ou, J.H. (1994) Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology 199, 124131.
  • [10]
    Lo, S., Masiarz, F., Hwang, S.B., Lai, M.M.C., Ou, J. (1995) Differential subcellular localization of hepatitis C virus core gene products. Virology 213, 455461.
  • [11]
    Yeh, C.-T., Lo, S.-Y., Dai, D.-I., Tang, J.-H., Chu, C.-M., Liaw, Y.-F. (2000) Amino acid substitutions in codons 9-11 of hepatitis C virus core protein led to the synthesis of a short core protein product. J. Gastroenterol. Hepatol. 15, 182191.
  • [12]
    Ruster, B., Zeuzem, S., Krump-Konvalinkova, V., Berg, T., Jonas, S., Severin, K., Roth, W.K. (2001) Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue. J. Med. Virol. 63, 128134.
  • [13]
    Shimoike, T., Mimori, S., Tani, H., Matsuura, Y., Miyamura, T. (1999) Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J. Virol. 73, 97189725.
  • [14]
    Yasui, K., Wakita, T., Kohara, K.-T., Funahashi, S.-I., Ichikawa, M., Kajita, T., Moradpour, D., Wands, J.R., Kohara, M. (1998) The native form and maturation process of hepatitis C virus core protein. J. Virol. 72, 60486055.
  • [15]
    Chamlian, A., Benkoel, L., Sahel, J., Cherid, A., Brisse, J., Ikoli, J.F., Lambert, R., Delamballerie, X. (1996) Immunohistochemical detection of hepatitis C virus related C100-3 and core antigens in formalin-fixed liver tissue. Cell. Mol. Biol. 42, 557566.
  • [16]
    Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., Koike, K. (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4, 10651067.
  • [17]
    Ray, R.B., Steele, R., Meyer, K., Ray, R. (1997) Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272, 1098310986.
  • [18]
    Bergqvist, A., Rice, C.M. (2001) Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J. Virol. 75, 772781.
  • [19]
    Lu, W., Lo, S.-Y., Chen, M., Wu, K.-J., Fung, Y.K.T., Ou, J.-H. (1999) Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264, 134141.
  • [20]
    Otsuka, M., Kato, N., Lan, K.-H., Yoshida, H., Kato, J., Goto, T., Shiratori, Y., Omata, M. (2000) Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 275, 3412234130.
  • [21]
    Shi, Y.-Z., Hui, A.-M., Takayama, T., Li, X., Cui, X., Makuuchi, M. (2000) Reduced p21waf1/CIP1 protein expression is predominantly related to altered p53 in hepatocellular carcinomas. Br. J. Can. Res. 83, 5055.
  • [22]
    Shrivastava, A., Manna, S.K., Ray, R., Aggarwal, B.B. (1998) Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J. Virol. 72, 97229728.
  • [23]
    Marusawa, H., Hijikata, M., Chiba, T., Shomotohno, K. (1999) Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation. J. Virol. 73, 47134720.
  • [24]
    Zhu, N., Khosnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C., Lai, M.M.C. (1998) Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72, 36913697.
  • [25]
    Fukuda, K., Tsuchihara, K., Hijikata, M., Nishiguchi, S., Kuroki, T., Shimotohno, K. (2001) Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli. Hepatology 33, 159165.
  • [26]
    Matsumoto, M., Hsieh, T.-Y., Zhu, N., VanArsdale, T., Hwang, S.B., Jeng, K.-S., Gorbalenya, A.E., Lo, S.-Y., Ou, J.-S., Ware, C.F., Lai, M.M.C. (1997) Hepatitis C virus core protein interacts with cytoplasmic tail of lymphotoxin-β receptor. J. Virol. 71, 13011309.
  • [27]
    Hahn, C.S., Cho, Y.G., Kang, B.-S., Lester, I.M., Hahn, Y.S. (2000) The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 276, 127137.
  • [28]
    Aoki, H., Hayashi, J., Moriyama, M., Arakawa, Y., Hino, O. (2000) Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J. Virol. 74, 17361741.
  • [29]
    Kittlesen, D.J., Chianese-Bullock, K.A., Yao, Z.Q., Braciale, T.J., Hahn, Y.S. (2000) Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106, 12391249.
  • [30]
    Jin, D.-Y., Wang, H.-L., Zhou, Y., Chun, A.C.S., Kibler, K.V., Hou, Y.-D., Kung, H.-F., Jeang, K.-T. (2000) Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transormation. EMBO J. 19, 729740.
  • [31]
    Ray, R.B., Meyer, K., Ray, R. (1996) Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226, 176182.
  • [32]
    Honda, M., Kaneko, S., Shimazaki, T., Matsushita, E., Kobayashi, K., Ping, L.-H., Zhang, H.-C., Lemon, S.M. (2000) Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 31, 13511359.
  • [33]
    Ray, R.B., Meyer, K., Steele, R., Shrivastava, A., Aggarwal, B.B., Ray, R. (1998) Inhibition of tumor necrosis factor (TNF-α) mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 273, 22562259.
  • [34]
    Lai, M.M.C., Ware, C.F. (2000) Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr. Top. Microbiol. Immunol. 242, 117134.
  • [35]
    Ruggieri, A., Harada, T., Matsuura, Y., Miyamura, T. (1997) Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229, 6876.
  • [36]
    Taya, N., Torimoto, Y., Shindo, M., Harai, K., Hasebe, C., Khogo, Y. (2000) Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. Br. J. Hematol. 110, 8997.
  • [37]
    Machida, K., Tsukiyama-Kohara, K., Seike, E., Tone, S., Shibasaki, F., Shimizu, M., Takahashi, H., Hayashi, Y., Funada, N., Taya, C., Yonekaea, H., Kohara, M. (2001) Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J. Biol. Chem. 276, 1214012146.
  • [38]
    Ray, R.B., Meyer, K., Ray, R. (2000) Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271, 197204.
  • [39]
    Pasquinelli, C., Shoenberger, J.M., Chung, J., Chang, K-M., Guidotti, L.G., Selby, M., Berger, K., Lesniewski, R., Houghton, M., Chisari, F.V. (1997) Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 25, 719727.
  • [40]
    Fujie, H., Yotsuyanagi, H., Moriya, K., Shintani, Y., Tsutsumi, T., Takayama, T., Makuuchi, M., Matsuura, Y., Miyamura, T., Kimura, S., Koike, K. (1999) Steatosis and intrahepatic hepatitis C virus in chronic hepatitis. J. Med. Virol. 59, 141145.
  • [41]
    Kawamura, T., Furusaka, A., Koziel, M.J., Chung, R.T., Wang, T.C., Schmidt, E.V., Liang, J. (1997) Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 25, 10141021.
  • [42]
    Weiner, A.J., Geysen, H.M., Christopherson, C., Hall, J.E., Mason, T.J., Saracco, G., Bonino, F., Crawford, K., Marion, C.D., Crawford, K.A., Brunetto, M., Barr, P.J., Miyamura, T., McHutchinson, J., Houghton, M. (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89, 34683472.
  • [43]
    Afonso, A.M.R., Jiang, J., Penin, F., Tareau, C., Samuel, D., Petit, M.-A., Bismuth, H., Dussaix, E., Feray, C. (1999) Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J. Virol. 73, 92139221.
  • [44]
    Bronowicki, J.P., Loriot, M.A., Thiers, V., Grignon, Y., Zignego, A.L., Brechot, C. (1998) Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 28, 211218.
  • [45]
    Lechmann, M., Woitas, R.P., Langhans, B., Kaiser, R., Ihlenfeldt, H.G., Jung, G., Sauerbruch, T., Spengler, U. (1999) Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J. Hepatol. 31, 19711978.
  • [46]
    Minton, E.J., Smillie, D., Neal, K.R., Irving, W.L., Underwood, J.C., James, V. (1998) Association between MHC class II alleles and clearance of circulating hepatitis C virus. J. Infect. Dis. 178, 3944.
  • [47]
    Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., Hori, M. (1999) Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162, 55845591.
  • [48]
    Lechner, F., Gruener, N.H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A., Cerny, A., Phillips, R., Ferrari, C., Pape, G.R., Klenerman, P. (2000) CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30, 24792487.
  • [49]
    Lagging, L.M., Meyer, K., Hoft, H., Houghton, M., Belshe, R.B., Ray, R. (1995) Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69, 58595863.
  • [50]
    Major, M.E., Vitvitski, L., Mink, M.A., Schleef, M., Whalen, R.G., Trepo, C., Inchauspe, G. (1995) DNA-Based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol. 69, 57985805.
  • [51]
    Geissler, M., Gesien, A., Tokushige, K., Wands, J. (1997) Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158, 12311237.
  • [52]
    Large, M.K., Kittlesen, D.J., Hahn, Y.S. (1999) Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J. Immunol. 162, 931938.
  • [53]
    Lee, C.H., Choi, Y.H., Yang, S.-H., Lee, C.W., Ha, S.J., Sung, Y.C. (2001) Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology 279, 271279.
  • [54]
    Polakos, N.K., Drane, D., Cox, J., Ng, P., Selby, M.J., Chien, D., O'Hagan, D.T., Houghton, M., Paliard, X. (2001) Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine. J. Immunol. 166, 35893598.